Nebenwirkungen · Actelsar HCT
Actelsar HCT 40 mg/12.5 mg tablets Actelsar HCT 80 mg/12.5 mg tablets · Abschnitt 4.8 · PDF-Seite 11
HOS-219565 · Präparat HOS-216393
Adverse reactions reported in all clinical trials and occurring more frequently (p≤0.05) with telmisartan plus hydrochlorothiazide than with placebo are shown below according to system organ class. Adverse reactions known to occur with each component given singly but which have not been seen in clinical trials may occur during treatment with Actelsar HCT. Adverse reactions previously reported with one of the individual components may be potential adverse reactions with Actelsar HCT, even if not observed in clinical trials with this product.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-13T15:14:00Z · SHA-256 197a1a05092cd299cb5198912aca4b5717f4c688699864a456a889050964eefc · Passage 67148149b54517f6bd51a64d9c4e5c0753ce97727566f296bea7319738291b36 · Zeichen 616–1162 im Abschnitt